-
Information-Publications
-
PRMT1 inhibition activates the interferon pathway to potentiate antitumor immunity and enhance checkpoint blockade efficacy in melanomaDetails -
Fibroblast growth factor 6 promotes adipocyte progenitor cell proliferation for adipose tissue homeostasisDetails -
Dapagliflozin alleviates renal podocyte pyroptosis via regulation of the HO‑1/NLRP3 axisDetails -
Exploring the role of SWI/SNF complex subunit BAF60c in lipid metabolism and inflammation in fishDetails -
Leveraging base excision repair for efficient adenine base editing of mitochondrial DNADetails -
Defining the sensitivity landscape of EGFR variants to tyrosine kinase inhibitorsDetails
-
"Heyuan Liji" is a joint venture between Heyuan Biotechnology (stock code: 688238) and Liji Biotechnology, specializing in the "Liji Biotechnology" and "Life-ilab" reagent brands
Back
